TN2010000607A1 - A new metroformin glycinate salt for blood glucose control - Google Patents
A new metroformin glycinate salt for blood glucose controlInfo
- Publication number
- TN2010000607A1 TN2010000607A1 TNP2010000607A TN2010000607A TN2010000607A1 TN 2010000607 A1 TN2010000607 A1 TN 2010000607A1 TN P2010000607 A TNP2010000607 A TN P2010000607A TN 2010000607 A TN2010000607 A TN 2010000607A TN 2010000607 A1 TN2010000607 A1 TN 2010000607A1
- Authority
- TN
- Tunisia
- Prior art keywords
- metformin
- salt
- glycine
- glycinate
- exhibits
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical class NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 title 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 8
- 239000004471 Glycine Substances 0.000 abstract 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical class CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 abstract 4
- KOFRCHIVYXPUNL-UHFFFAOYSA-N 2-aminoacetic acid;3-(diaminomethylidene)-1,1-dimethylguanidine Chemical compound NCC(O)=O.CN(C)C(=N)N=C(N)N KOFRCHIVYXPUNL-UHFFFAOYSA-N 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 229960003105 metformin Drugs 0.000 abstract 2
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- -1 1,1 -dimethylbiguanide Glycinate salt Chemical class 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 229950007228 metformin glycinate Drugs 0.000 abstract 1
- 229960004329 metformin hydrochloride Drugs 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2008/002665 WO2009144527A1 (fr) | 2008-06-26 | 2008-06-26 | Nouveau sel de metformine glycinate pour régulation de la glycémie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000607A1 true TN2010000607A1 (en) | 2012-05-24 |
Family
ID=40383805
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000607A TN2010000607A1 (en) | 2008-06-26 | 2010-12-27 | A new metroformin glycinate salt for blood glucose control |
| TNP2010000604A TN2010000604A1 (en) | 2008-06-26 | 2010-12-27 | A new metformin glycinate salt for blood glucose control |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000604A TN2010000604A1 (en) | 2008-06-26 | 2010-12-27 | A new metformin glycinate salt for blood glucose control |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8703183B2 (fr) |
| EP (1) | EP2303838B1 (fr) |
| JP (1) | JP5551691B2 (fr) |
| KR (1) | KR101522066B1 (fr) |
| CN (1) | CN102159539B (fr) |
| AR (1) | AR074159A1 (fr) |
| AU (1) | AU2008357111B2 (fr) |
| BR (1) | BRPI0822909B8 (fr) |
| CA (1) | CA2729035C (fr) |
| CL (1) | CL2009001484A1 (fr) |
| CY (1) | CY1115098T1 (fr) |
| DK (1) | DK2303838T3 (fr) |
| EC (1) | ECSP10010719A (fr) |
| ES (1) | ES2450148T3 (fr) |
| HR (1) | HRP20140194T1 (fr) |
| JO (1) | JO2884B1 (fr) |
| MA (1) | MA32418B1 (fr) |
| MX (1) | MX2011000135A (fr) |
| NI (1) | NI201000234A (fr) |
| PE (1) | PE20100257A1 (fr) |
| PL (1) | PL2303838T3 (fr) |
| PT (1) | PT2303838E (fr) |
| SI (1) | SI2303838T1 (fr) |
| TN (2) | TN2010000607A1 (fr) |
| UY (1) | UY31945A (fr) |
| WO (1) | WO2009144527A1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2450148T3 (es) | 2008-06-26 | 2014-03-24 | Laboratorios Silanes, S.A. De C.V. | Una nueva sal de glicinato de metformina para el control de la glucosa en sangre |
| US9382187B2 (en) | 2012-07-10 | 2016-07-05 | Thetis Pharmaceuticals Llc | Tri-salt form of metformin |
| US8765811B2 (en) | 2012-07-10 | 2014-07-01 | Thetis Pharmaceuticals Llc | Tri-salt form of metformin |
| US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
| US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
| CN103263405B (zh) * | 2013-05-08 | 2015-04-22 | 南京医科大学 | 用于治疗糖尿病的药物组合物及其应用 |
| US9815777B2 (en) | 2013-09-22 | 2017-11-14 | Jiva Pharma, Inc. | Metformin salts to treat Type2 diabetes |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
| EP3140316A1 (fr) | 2014-05-05 | 2017-03-15 | Thetis Pharmaceuticals LLC | Compositions et procédés se rapportant à des sels ioniques de peptides |
| WO2015183794A1 (fr) * | 2014-05-27 | 2015-12-03 | City Of Hope | Complexes d'agonistes de tgr5 pour le traitement du diabète et du cancer |
| US9242008B2 (en) | 2014-06-18 | 2016-01-26 | Thetis Pharmaceuticals Llc | Mineral amino-acid complexes of fatty acids |
| AU2015277509A1 (en) | 2014-06-18 | 2017-01-05 | Thetis Pharmaceuticals Llc | Mineral amino-acid complexes of active agents |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| EP3933845A3 (fr) | 2014-10-27 | 2022-06-22 | Aseko, Inc. | Gestion sous-cutanée de patient externe |
| CN105030745A (zh) * | 2015-07-08 | 2015-11-11 | 南京医科大学 | 甘氨酸和二甲双胍的酰胺化产物在制备治疗糖尿病药物中的应用 |
| AU2016308953B2 (en) | 2015-08-20 | 2020-09-10 | Glytec, Llc | Diabetes management therapy advisor |
| WO2017210604A1 (fr) | 2016-06-03 | 2017-12-07 | Thetis Pharmaceuticals Llc | Compositions et procédés relatifs à des sels de médiateurs spécialisés de pro-résolution d'inflammation |
| WO2018060962A2 (fr) | 2016-09-30 | 2018-04-05 | Laboratorios Silanes S.A. De C.V. | Composés d'acides aminés de metformine et leurs procédés d'utilisation |
| US11185516B2 (en) | 2016-09-30 | 2021-11-30 | Laboratorios Silanes S.A. De C.V. | Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same |
| CN113105367B (zh) | 2021-03-30 | 2022-08-02 | 广州大学 | 一类二甲双胍盐及其制备方法和应用 |
| CN114349665B (zh) * | 2021-11-30 | 2023-06-09 | 潍坊博创国际生物医药研究院 | 二甲双胍焦谷氨酸晶体及其制备方法与应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE568513A (fr) | ||||
| FR2037002A1 (en) | 1969-04-30 | 1970-12-31 | Roques Bernard | N-substd biguanide pamoic acid salts prepn |
| DE1967138A1 (de) | 1969-07-17 | 1977-11-10 | Christian Brunnengraeber Chem | Therapeutisches mittel |
| AT325632B (de) | 1973-06-01 | 1975-10-27 | Hurka Wilhelm | Verfahren zur herstellung von nicotinsauren salzen von derivaten des biguanids |
| FR2243684B1 (fr) | 1973-09-19 | 1977-01-28 | Semb | |
| CH602612A5 (fr) | 1974-10-11 | 1978-07-31 | Hoffmann La Roche | |
| FR2320735A1 (fr) | 1975-08-12 | 1977-03-11 | Dabis Georges | Composition anti-cellulite |
| JPS57179494A (en) | 1981-04-30 | 1982-11-05 | Mitsubishi Plastics Ind | Method of closing through hole of pipe, circumferential wall thereof has through hole in pipe axial direction |
| FR2585572B3 (fr) | 1985-07-31 | 1987-12-31 | Hugelin Andre | Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse |
| PT793646E (pt) * | 1994-11-23 | 2002-03-28 | Biovitrum Ab | Carboxilatos de aminoguanidina destinados ao tratamento de diabetes mellitus nao-insulinodependente |
| JP4278863B2 (ja) | 1997-12-08 | 2009-06-17 | ブリストル−マイヤーズ スクイブ カンパニー | メトホルミンの新規塩および方法 |
| US6936275B2 (en) | 1999-12-20 | 2005-08-30 | Scolr, Inc. | Amino acid modulated extended release dosage form |
| AU2003211131A1 (en) * | 2002-02-14 | 2003-09-04 | Sonus Pharmaceuticals, Inc. | Metformin salts of lipophilic acids |
| US7181457B2 (en) * | 2003-05-28 | 2007-02-20 | Pervasive Software, Inc. | System and method for utilizing compression in database caches to facilitate access to database information |
| AU2004285535A1 (en) | 2003-10-31 | 2005-05-12 | Alza Corporation | Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| WO2005065675A1 (fr) | 2004-01-07 | 2005-07-21 | Premacs International Pty. Ltd. | Methode de traitement |
| EP2242489A1 (fr) * | 2005-02-15 | 2010-10-27 | Jallal Messadek | Compositions therapeutiques combinees et leurs procedes d utilisation |
| MX2007013486A (es) * | 2005-04-27 | 2008-03-14 | Jallal Messadek | Combinaciones de insulinas. |
| CA2691775A1 (fr) * | 2006-06-16 | 2007-12-27 | Indigene Pharmaceuticals Inc. | Lipoate de metformine r-(+) utilise comme antidiabetique contr l'hyperglycemie diabetique et les complications diabetiques |
| NZ556735A (en) * | 2007-07-24 | 2009-03-31 | Vector Ltd | Securing devices and equipotential bonding system |
| ES2450148T3 (es) | 2008-06-26 | 2014-03-24 | Laboratorios Silanes, S.A. De C.V. | Una nueva sal de glicinato de metformina para el control de la glucosa en sangre |
-
2008
- 2008-06-26 ES ES08807218.6T patent/ES2450148T3/es active Active
- 2008-06-26 PT PT88072186T patent/PT2303838E/pt unknown
- 2008-06-26 WO PCT/IB2008/002665 patent/WO2009144527A1/fr not_active Ceased
- 2008-06-26 HR HRP20140194AT patent/HRP20140194T1/hr unknown
- 2008-06-26 CN CN200880130084.3A patent/CN102159539B/zh active Active
- 2008-06-26 DK DK08807218.6T patent/DK2303838T3/en active
- 2008-06-26 CA CA2729035A patent/CA2729035C/fr not_active Expired - Fee Related
- 2008-06-26 JP JP2011515639A patent/JP5551691B2/ja not_active Expired - Fee Related
- 2008-06-26 AU AU2008357111A patent/AU2008357111B2/en not_active Ceased
- 2008-06-26 PL PL08807218T patent/PL2303838T3/pl unknown
- 2008-06-26 KR KR1020117000071A patent/KR101522066B1/ko not_active Expired - Fee Related
- 2008-06-26 MX MX2011000135A patent/MX2011000135A/es active IP Right Grant
- 2008-06-26 BR BRPI0822909A patent/BRPI0822909B8/pt active IP Right Grant
- 2008-06-26 EP EP08807218.6A patent/EP2303838B1/fr not_active Not-in-force
- 2008-06-26 SI SI200831163T patent/SI2303838T1/sl unknown
-
2009
- 2009-06-25 PE PE2009000908A patent/PE20100257A1/es active IP Right Grant
- 2009-06-25 CL CL2009001484A patent/CL2009001484A1/es unknown
- 2009-06-25 JO JO2009233A patent/JO2884B1/en active
- 2009-06-26 UY UY0001031945A patent/UY31945A/es not_active Application Discontinuation
- 2009-06-26 AR ARP090102388A patent/AR074159A1/es unknown
-
2010
- 2010-12-23 NI NI201000234A patent/NI201000234A/es unknown
- 2010-12-24 US US12/928,985 patent/US8703183B2/en not_active Ceased
- 2010-12-24 EC EC2010010719A patent/ECSP10010719A/es unknown
- 2010-12-27 TN TNP2010000607A patent/TN2010000607A1/fr unknown
- 2010-12-27 MA MA33460A patent/MA32418B1/fr unknown
- 2010-12-27 TN TNP2010000604A patent/TN2010000604A1/fr unknown
-
2014
- 2014-02-25 CY CY20141100150T patent/CY1115098T1/el unknown
-
2016
- 2016-04-21 US US15/135,018 patent/USRE46496E1/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO2884B1 (en) | New metformin glycinate salt to control blood glucose | |
| CN103827127B (zh) | 草铵膦p游离酸的制造方法 | |
| DK2057126T3 (da) | Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater | |
| JP7373598B2 (ja) | ジヌクレオシドポリリン酸化合物の製造方法 | |
| BR112012007869B1 (pt) | Processo de síntese de ergotioneína e seus derivados | |
| Butov et al. | Synthesis and properties of symmetrical N, N'-Bis (R-adamantan-1-yl) ureas as target-oriented soluble epoxide hydrolase (sEH) inhibitors | |
| AR078135A1 (es) | Un proceso para la preparacion de derivados de cianoalquilpropionato. | |
| CN106699586B (zh) | 门冬氨酸鸟氨酸的制备方法 | |
| Tatikonda et al. | Synthesis and characterization of Zwitterionic Zn (II) and Cu (II) coordination compounds with ring-substituted 2, 2′-biimidazole derivatives | |
| ES2878083T3 (es) | Método para purificar P1,P4-di(uridina 5'-)tetrafosfato | |
| CN105523985A (zh) | 一种维格列汀的制备方法 | |
| WO2007053536A3 (fr) | Reaction de cocristallisation de complexes moleculaires ou cocristaux | |
| AR127964A1 (es) | Sal novedosa de un derivado de 1-sulfonilpirrol, método de preparación de la misma y composición farmacéutica que comprende la misma | |
| Petrović et al. | Kinetic studies on the reactions of [Pd (dach)(X–Y)] complexes with some DNA constituents | |
| DE602007013796D1 (de) | Ausstossflüssigkeit und ausstossverfahren | |
| CN103981248A (zh) | 一种拆分外消旋亮氨酸的方法 | |
| CN102206160A (zh) | 一种2-氨基苯胺盐酸盐的制备及合成方法 | |
| Fomina et al. | SYNTHESIS OF CYANINE DYES WITH TERMINAL NITROGEN-CONTAINING GROUPS AND THEIR SELF-ASSEMBLED SUPRAMOLECULARCOMPLEXES WITH CAVITANDS | |
| CA3156793A1 (fr) | Guanidines chirales, sels de celles-ci, procedes de fabrication de guanidines chirales et de leurs sels, et utilisations de guanidines chirales et de leurs sels dans la preparation d'acides amines enantiomeriquement pur | |
| EA200701270A1 (ru) | Композиция и способы получения 13-дезоксиантрациклинов | |
| CO6331332A2 (es) | Una nueva sal de glicinato de metformina para el control de glucosa en sangre | |
| DOP2010000403A (es) | Una nueva sal de glicinato de metformina para el control de la glucosa en sangre | |
| IT202100019529A1 (it) | Metodo di sintesi di derivati del glutatione | |
| RU2012137737A (ru) | Способ получения бета-дикетоната или бета-кетоимината палладия (ii) | |
| RU2528828C1 (ru) | Способ получения 5,7-бис-(фениламино)-4,6-динитробензофуроксана |